Further support for these findings was provided in a study reporting notable increases in ALP, ALT, and AST in T2DM patients, which linked these alterations to hepatic insulin resistance and oxidative stress as the primary metabolic driver. This evidence concerns the gene GPT and type 2 diabetes mellitus.